Emmie’s experience with adaptive automated insulin delivery

mylife Stories

After trying various therapy options, Emmie met with our mylife team to discuss a possible switch to mylife Loop: as one of the only licensed loop systems available for children. In just a couple of weeks Emmie and her family have already started to see a positive change to their lives.

Ypsomed has entered into a cooperation with CamDiab Ltd. to further simplify your diabetes therapy. CamDiab Ltd. is the developer of CamAPS FX, an easy to set up and use app which works seamlessly with your Dexcom G6 sensor and your mylife YpsoPump insulin pump. Thanks to the upcoming integration of automated insulin delivery into the mylife YpsoPump system, you will be afforded more time away from your diabetes, and more spontaneity in your daily life. This easy-to-use loop solution will be launched for the mylife YpsoPump system, starting in selected countries and followed by other Ypsomed territories in the course of the year.

Ypsomed partners with Dexcom

mylife Stories

We have recently entered a partnership with Dexcom to improve your diabetes therapy system. This partnership will make it possible for you to use the Dexcom G6 CGM system as part of the mylife Diabetescare therapy system. Thanks to this integration, you will be able to review mylife YpsoPump insulin data as well as Dexcom’s continuous glucose monitoring data in your mylife App on your smartphone.

Burgdorf/San Diego – Ypsomed (SWX:YPSN) and DexCom Inc. (NASDAQ:DXCM), the world's leading provider of continuous glucose monitoring (CGM) systems, announce their partnership to drive development of a hybrid closed loop system. The partnership is an important milestone in the further development of individualised diabetes therapy. In a first step, CGM data from Dexcom will be integrated into the mylife App from Ypsomed.